Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPLACIZUMAB for Product used for unknown indication: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where CAPLACIZUMAB was used for Product used for unknown indication.

Most Reported Side Effects for CAPLACIZUMAB

Side Effect Reports % Deaths Hosp.
Off label use 26 17.9% 5 8
Condition aggravated 13 9.0% 5 8
Platelet count decreased 12 8.3% 2 5
Drug ineffective 10 6.9% 2 4
Maternal exposure during pregnancy 10 6.9% 1 0
Pyrexia 10 6.9% 1 9
Thrombotic thrombocytopenic purpura 10 6.9% 3 5
Foetal exposure during pregnancy 9 6.2% 4 0
Foetal growth restriction 9 6.2% 4 0
Haemorrhage 9 6.2% 1 4
Deep vein thrombosis 8 5.5% 0 7
Disease recurrence 8 5.5% 0 2
Epistaxis 8 5.5% 0 2
Thrombosis 8 5.5% 0 1
Oligohydramnios 7 4.8% 0 0

Other Indications for CAPLACIZUMAB

Thrombotic thrombocytopenic purpura (97) Immune thrombocytopenia (11)

Other Drugs Used for Product used for unknown indication

OXYCODONE (129,391) ADAPALENE (91,681) APIXABAN (88,417) ETANERCEPT (71,866) SACUBITRIL\VALSARTAN (69,693) ACETAMINOPHEN (68,427) AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206) ADALIMUMAB (63,549) EVOLOCUMAB (60,696) MORPHINE (59,440)

Related Pages

CAPLACIZUMAB Full Profile All Product used for unknown indication Drugs CAPLACIZUMAB Demographics CAPLACIZUMAB Timeline